Disintegrating planets are an extremely rare subcategory of USPs—only those hot enough to evaporate their surfaces and small enough that they cannot hold onto the material gravitationally can be ...

NASA’s TESS identifies BD+05 4868 Ab, a rapidly disintegrating exoplane The planet loses mass equivalent to Earth's moon every million years Researchers to study it further using the James Webb Space ...

In addition, Sunshine Biopharma is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and (ii) PLpro protease ...

Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company currently valued at $5.8 million and showing promising revenue growth of 62% over the last twelve months, announced the release of two ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has ...

can be repeated once after 1 h (max 12 mg/day) Zolmitriptan – Zomig®, Zomig® ZMT 2.5, 5 mg tablets; 2.5, 5 mg orally disintegrating tablets 5 mg/100 mcl nasal spray 2.5 or 5 mg p.o.; can be ...

The SAD study involved 40 obese subjects under fasting conditions. Credit: earth phakphum/Shutterstock. Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending ...

It released its first Android smartphone in 2009, and can be credited with the launch of the first Android tablet back in 2010. The company is among the biggest players in the smartphone market in the ...

It is formulated as a once-daily oral disintegrating tablet for sublingual administration, for ease of use in an elderly population. The firm’s ITI-333, a partial agonist of μ−opioid ...

KalVista is currently transitioning ongoing participants in the trial to a novel oral disintegrating tablet (ODT) formulation to support a planned 2026 sNDA filing. If approved, the ODT formulation ...